Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Chapter 1 UK Renal Replacement Therapy Adult Incidence in 2016: National and Centre-specific Analyses.

Hole B, Gilg J, Casula A, Methven S, Castledine C.

Nephron. 2018;139 Suppl 1:13-46. doi: 10.1159/000490959. Epub 2018 Jul 10. No abstract available.

2.

Outcomes of immunosuppression in IgA nephropathy based on the oxford classification.

Palamuthusingam D, Castledine C, Lawman S.

Saudi J Kidney Dis Transpl. 2018 Mar-Apr;29(2):341-350. doi: 10.4103/1319-2442.229292.

3.

UK Renal Registry 19th Annual Report: Chapter 1 UK RRT Adult Incidence in 2015: National and Centre-specific Analyses.

Gilg J, Methven S, Casula A, Castledine C.

Nephron. 2017;137 Suppl 1:11-44. doi: 10.1159/000481363. Epub 2017 Sep 29. No abstract available.

4.

Racial Disparity in Access to Home Therapies-We Have the Power to Change.

Castledine C.

Perit Dial Int. 2017 Jan 2;37(1):4-5. doi: 10.3747/pdi.2016.00182. No abstract available.

PMID:
28153963
5.

UK Renal Registry 18th Annual Report: Chapter 2 UK Renal Replacement Therapy Prevalence in 2014: National and Centre-specific Analyses.

MacNeill SJ, Casula A, Shaw C, Castledine C.

Nephron. 2016;132 Suppl 1:41-68. doi: 10.1159/000444816. Epub 2016 Apr 19.

6.

Setting Priorities for Optimizing Vascular Access Decision Making--An International Survey of Patients and Clinicians.

van der Veer SN, Haller MC, Pittens CA, Broerse J, Castledine C, Gallieni M, Inston N, Marti Monros A, Peek N, van Biesen W.

PLoS One. 2015 Jul 7;10(7):e0128228. doi: 10.1371/journal.pone.0128228. eCollection 2015.

7.

UK Renal Registry 17th Annual Report: Chapter 2 UK Renal Replacement Therapy Prevalence in 2013: National and Centre-specific Analyses.

Rao A, Casula A, Castledine C.

Nephron. 2015;129 Suppl 1:31-56. doi: 10.1159/000370272. Epub 2015 Jan 22.

8.

Dialysis modality after renal transplant failure.

Castledine C, Caskey FJ.

Perit Dial Int. 2013 Nov-Dec;33(6):600-3. doi: 10.3747/pdi.2013.00087. No abstract available.

9.

Estimated GFR reporting influences recommendations for dialysis initiation.

Brimble KS, Mehrotra R, Tonelli M, Hawley CM, Castledine C, McDonald SP, Levidiotis V, Gangji AS, Treleaven DJ, Margetts PJ, Walsh M.

J Am Soc Nephrol. 2013 Nov;24(11):1737-42. doi: 10.1681/ASN.2013010035. Epub 2013 Aug 29.

10.

Renal centre characteristics and physician practice patterns associated with home dialysis use.

Castledine CI, Gilg JA, Rogers C, Ben-Shlomo Y, Caskey FJ.

Nephrol Dial Transplant. 2013 Aug;28(8):2169-80. doi: 10.1093/ndt/gft196. Epub 2013 Jun 4.

PMID:
23737483
11.

Chapter 2 UK RRT prevalence in 2010: national and centre-specific analyses.

Castledine C, Casula A, Fogarty D.

Nephron Clin Pract. 2012;120 Suppl 1:c29-54. Epub 2012 Sep 1.

PMID:
22964573
12.

Chapter 6 Survival and causes of death of UK adult patients on renal replacement therapy in 2010: national and centre-specific analyses.

Steenkamp R, Castledine C, Feest T.

Nephron Clin Pract. 2012;120 Suppl 1:c105-35. Epub 2012 Sep 1.

PMID:
22964564
13.

Chapter 1 UK RRT incidence in 2010: national and centre-specific analyses.

Gilg J, Castledine C, Fogarty D.

Nephron Clin Pract. 2012;120 Suppl 1:c1-27. Epub 2012 Sep 1.

PMID:
22964563
14.

How much of the regional variation in RRT incidence rates within the UK is explained by the health needs of the general population?

Castledine CI, Gilg JA, Rogers C, Ben-Shlomo Y, Caskey FJ.

Nephrol Dial Transplant. 2012 Oct;27(10):3943-50. doi: 10.1093/ndt/gfs294. Epub 2012 Jul 9.

PMID:
22778180
15.

Trends in renal replacement therapy and changes in peritoneal dialysis utilization in the United kingdom.

Castledine CI, Caskey FJ, Tomson CR, Ansell D.

Perit Dial Int. 2011 Mar;31 Suppl 2:S53-7. doi: 10.3747/pdi.2009.00194. No abstract available.

PMID:
21364209
16.

UK Renal Registry 13th Annual Report (December 2010): Chapter 5: demography of the UK paediatric renal replacement therapy population in 2009.

Sinha MD, Castledine C, van Schalkwyk D, Hussain F, Lewis M, Inward C.

Nephron Clin Pract. 2011;119 Suppl 2:c97-106. doi: 10.1159/000331755. Epub 2011 Aug 26.

17.

UK Renal Registry 13th Annual Report (December 2010): Chapter 2: UK RRT prevalence in 2009: national and centre-specific analyses.

Steenkamp R, Castledine C, Feest T, Fogarty D.

Nephron Clin Pract. 2011;119 Suppl 2:c27-52. doi: 10.1159/000331744. Epub 2011 Aug 26.

18.

UK Renal Registry 13th Annual Report (December 2010): Chapter 15: UK renal centre survey results 2010: RRT incidence and use of home dialysis modalities.

Castledine C, Gilg J, Rogers C, Ben-Shlomo Y, Caskey F.

Nephron Clin Pract. 2011;119 Suppl 2:c255-67. doi: 10.1159/000331783. Epub 2011 Aug 26.

19.
21.

UK Renal Registry 13th Annual Report (December 2010): Chapter 7: the relationship between the type of vascular access used and survival in UK RRT patients in 2006.

Castledine C, van Schalkwyk D, Feest T.

Nephron Clin Pract. 2011;119 Suppl 2:c135-40. doi: 10.1159/000331757. Epub 2011 Aug 26.

22.

UK Renal Registry 13th Annual Report (December 2010): Chapter 6: survival and causes of death of UK adult patients on renal replacement therapy in 2009: national and centre-specific analyses.

Castledine C, Steenkamp R, Feest T, Tomson CR.

Nephron Clin Pract. 2011;119 Suppl 2:c107-34. doi: 10.1159/000331756. Epub 2011 Aug 26.

23.

UK Renal Registry 13th Annual Report (December 2010): Chapter 1: UK RRT incidence in 2009: national and centre-specific analyses.

Gilg J, Castledine C, Fogarty D, Feest T.

Nephron Clin Pract. 2011;119 Suppl 2:c1-25. doi: 10.1159/000331741. Epub 2011 Aug 26.

24.

UK Renal Registry 12th Annual Report (December 2009): chapter 4: UK ESRD prevalent rates in 2008: national and centre-specific analyses.

Byrne C, Steenkamp R, Castledine C, Ansell D, Feehally J.

Nephron Clin Pract. 2010;115 Suppl 1:c41-67. doi: 10.1159/000301159. Epub 2010 Mar 31.

25.
26.

UK Renal Registry 12th Annual Report (December 2009): chapter 14: demography of the UK paediatric renal replacement therapy population in 2008.

Lewis MA, Shaw J, Sinha MD, Adalat S, Hussain F, Castledine C, van Schalkwyk D, Inward C.

Nephron Clin Pract. 2010;115 Suppl 1:c279-88. doi: 10.1159/000301237. Epub 2010 Mar 31.

27.

UK Renal Registry 12th Annual Report (December 2009): chapter 10: biochemistry profile of patients receiving dialysis in the UK in 2008: national and centre-specific analyses.

Dawnay A, Farrington K, Castledine C, van Schalkwyk D, Warwick G.

Nephron Clin Pract. 2010;115 Suppl 1:c187-237. doi: 10.1159/000301233. Epub 2010 Mar 31.

28.

UK Renal Registry 12th Annual Report (December 2009): chapter 8: adequacy of haemodialysis in UK renal centres in 2008: national and centre-specific analyses.

Williams AJ, Castledine C, Casula A, Warwick G.

Nephron Clin Pract. 2010;115 Suppl 1:c145-52. doi: 10.1159/000301163. Epub 2010 Mar 31.

29.

Rosiglitazone as a cause of acute interstitial nephritis.

Castledine C, Wright D, Kingdon E.

Nephrol Dial Transplant. 2006 Jul;21(7):1994-5. Epub 2006 Feb 28. No abstract available.

PMID:
16507580
30.

Nursing assessment of the musculoskeletal system.

Castledine C.

Nursing (Lond). 1979 Jun;(3):148-9. No abstract available.

PMID:
261280

Supplemental Content

Loading ...
Support Center